
Celon Pharma S.A.
CLN | WSX
Overview
Corporate Details
- ISIN(s):
- PLCLNPH00015 (+3 more)
- LEI:
- 259400Q0ERJT0NC5DT24
- Country:
- Poland
- Address:
- KAZUŃ NOWY MARYMONCKA 15, 05-152 KAZUŃ NOWY
- Website:
- https://celonpharma.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life. One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective drugs. The research and development department in Celon Pharma S.A.employs over 160 scientists, of which one in four have PhD titles in molecular biology, pharmacy or chemistry. We invest in the development of innovative pharmaceutical products which have the potential to treat cancers, neurological diseases, diabetes and other metabolic disorders. We have obtained financial resources for research into new drugs from the sale of generic drugs, as well as from the EU funds obtained under the Innovative Economy programme.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-03 09:16 |
Regulatory News Service
Przekazanie informacji o wprowadzeniu produktu leczniczego TIKOZEK do regulator…
|
Polish | 1021 bytes | |
2025-05-30 17:57 |
Remuneration Report
zal05_Sprawozdanie_o_wynagrodzeniach_Czlonkow_Zarzadu_i_RN_Celon_Pharma_SA_za_2…
|
Polish | 274.1 KB | |
2025-05-30 17:57 |
Remuneration Report
zal04_Projekt_Polityka_Wynagrodzen_zalacznik_do_uchwaly_nr_17_ZWZ_Celon_Pharma_…
|
Polish | 149.4 KB | |
2025-05-30 17:57 |
Annual Report
zal03_Celon_Pharma_Sprawozdanie_Rady_Nadzorczej_za_2024.pdf
|
Polish | 672.4 KB | |
2025-05-30 17:57 |
Declaration of Voting Results & Voting Rights Announcements
zal01_Celon_Pharma_Projekty_uchwal_na_ZWZ_26_06_2025.pdf
|
Polish | 258.6 KB | |
2025-05-30 17:57 |
General Meeting Notice
zal02_Celon_Pharma_Ogloszenie_o_zwolaniu_ZWZ_26_06_2025.pdf
|
Polish | 243.1 KB | |
2025-05-30 17:57 |
General Meeting Notice
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Celon Pharma S.A. na dzi…
|
Polish | 2.7 KB | |
2025-05-21 17:05 |
Interim Report
Raport za 1 kwartał 2025
|
Polish | 2.0 MB | |
2025-05-06 15:48 |
Regulatory News Service
Podpisanie umowy o objęcie wsparciem projektu Celon Pharma S.A. w ramach Krajow…
|
Polish | 2.9 KB | |
2025-04-30 22:59 |
Regulatory News Service
zal08_24_CP_Sprawozdanie_z_badania.T.xhtml.xades
|
Polish | 9.2 KB | |
2025-04-30 22:59 |
Regulatory News Service
Sprawozdanie niezależnego biegłego rewidenta z badania rocznego sprawozdania fi…
|
Polish | 3.3 MB | |
2025-04-30 22:59 |
Regulatory News Service
zal06_SZA_ESG_CPSA-2024-12-31-0-pl.xhtml.XAdES
|
English | 10.0 KB | |
2025-04-30 22:59 |
Regulatory News Service
SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA z atestacji sprawozdawczości zrów…
|
Polish | 1.8 MB | |
2025-04-30 22:59 |
Regulatory News Service
Oświadczenie RN ws KA
|
Polish | 2.1 MB | |
2025-04-30 22:59 |
Regulatory News Service
zal04_Oswiadczenie_Zarzadu_ws_rzetelnosci_2025-04-30.xhtml.xades
|
Polish | 15.3 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Antibiotice S.A. | Romania | ATB | |
![]() |
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
![]() |
Asarina Pharma AB | Sweden | ASAP |